These Healthcare stocks are trading higher:
-ABVC Biopharma Inc (ABVC) stock is trading at $5.80, a gain of $2, or 53.42%, on high volume. Abvc Biopharma Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $2.02. Abvc Biopharma Inc next reports earnings on August 21.
-Vincerx Pharma Inc (VINC) stock is trading at $1.26, an increase of $0.26, or 26%, on moderate volume. Vincera Pharma Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.00. Vincera Pharma Inc next reports earnings on August 10.
-Teladoc Health Inc (TDOC) stock is trading at $28.59, a rise of $5.81, or 25.5%, on high volume. Teladoc Health Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $31.11.
-Tilray Brands Inc (TLRY) stock is trading at $1.98, a gain of $0.3, or 16.96%, on high volume. Tilray Brands Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $3.04.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Healthcare Services Group, Inc. (HCSG) stock is trading at $12.59, a decline of $2.1, or 14.16%, on high volume. Healthcare Svcs Gp gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $16.33.
-Mangoceuticals Inc (MGRX) stock is trading at $1.13, a decline of $0.17, or 13.46%, on low volume. Mangoceuticals Inc gets a Sentiment Score of Bearish from InvestorsObserver.
-SAGE Therapeutics Inc (SAGE) stock is trading at $36.40, a decline of $5.44, or 12.98%, on high volume. Sage Therapeutic Com gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $58.17. Sage Therapeutic Com next reports earnings on August 1.
-Inozyme Pharma Inc (INZY) stock is trading at $5.51, a decline of $0.66, or 10.94%, on moderate volume. Inozyme Pharma Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $20.83. Inozyme Pharma Inc next reports earnings on August 21.
Find the top stocks in the Healthcare Sector here.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
